Key facts
- This page summarizes Kristin A. Ferge's Form 4 filing for Neuraxis, INC (NRXS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2026, 18:28.
Kristin A. Ferge - 13 Aug 2026 Form 4 Insider Report for Neuraxis, INC (NRXS)
- Reporting relationship
- Director
- Issuer ticker
- NRXS
- Reported as of
- 13 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Aug 2026, 18:28:40 UTC
- Prior SEC filing
- 30 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristin Ferge
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kristin A. Ferge filed Form 4 for Neuraxis, INC (NRXS) on 17 Aug 2026.
Change
- Previous filing in this sequence was filed on 30 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001343345
Primary reporting owner
Ferge Kristin A
- Relationship
- Director
- Address
- 11611 N. MERIDIAN ST,, SUITE 330, CARMEL
- Signature
- /s/ Kristin Ferge
- Signature date
- 17 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NRXS
transaction
Common Stock
Award
- Transaction value
- Shares
- +31,134
- Change %
- +87%
- Price
- $6.28*
- Shares after
- 67,072
- Date
- 13 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.